Search results
Where Is Amgen Headed After the Stock Surges on Obesity Drug News?
TheStreet.com· 4 days agoThe company also "tweaked" their forward guidance and the stock was raised to a fundamental...
Amgen (AMGN) Q1 Earnings Top, Stock Up on Obesity Drug Update
Zacks via Yahoo Finance· 3 days agoAmgen (AMGN) beats first-quarter 2024 estimates for earnings and sales. Amgen is "very encouraged"...
Check Out What Whales Are Doing With AMGN - Amgen (NASDAQ:AMGN)
Benzinga· 12 hours agoFlagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced ...
Pfizer (PFE) Reports Q1 Earnings: What Key Metrics Have to Say
Zacks via Yahoo Finance· 6 days agoWhile the top- and bottom-line numbers for Pfizer (PFE) give a sense of how the business performed...
Amgen 'encouraged' by weight-loss drug interim data, shares jump
Reuters via AOL· 4 days ago(Reuters) -Amgen on Thursday said it was very encouraged after completing an interim analysis of its...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 5 days agoPrevnar sales inched 2% ahead to $6.44 billion. But other key products saw downfalls. Revenue from...
Here's What Key Metrics Tell Us About Amgen (AMGN) Q1 Earnings
Zacks· 5 days agoThe headline numbers for Amgen (AMGN) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Siliq and cost: Reducing long-term drug costs and more
Medical News Today· 4 days agoSiliq (brodalumab) is a brand-name subcutaneous injection prescribed for plaque psoriasis in adults...
Decoding Amgen Inc (AMGN): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 3 days agoGlobal Reach and Market Share: With a presence in over 100 countries, Amgen Inc has established a significant global footprint. Its leading products,...
What to Watch in the Day Ahead - Thursday, May 2
Reuters via Yahoo Finance· 5 days agoInvestors will expect commentary on how it plans to revive sales and updates on AI development, which is driving gains at Big Tech peers. Moderna is expected report first-quarter earnings, as ...